|
|
| Molecular Detection Inc. (MDI) is applying its proprietary technologies to develop and market Detect-Ready™ molecular diagnostic tests to increase the speed, accuracy, ease of use, and efficiency of infectious disease diagnosis. |
|
|
|
|
|
|
|
|
| DETECT-READY™ MRSA ASSAY: |
|
 | | MDI's first Detect-Ready™ assay is a ready-to-use, "sample-to-answer" rapid detection screening test for the growing problem of MRSA (methicillin-resistant S. aureus) infection, a costly and potentially deadly pathogen increasingly found in hospitals and other health facilities worldwide. more... |
| |
| |
|
|
|
| ABOUT MDI: |
|
 | | Molecular Detection Inc. (MDI) is developing and commercializing a portfolio of sample-to-answer Detect-Ready™ molecular diagnostic tests for the rapid detection of infectious diseases. MDI recently launched the Detect-Ready™ assay for the rapid diagnosis of MRSA in Germany and the U.K. more... |
| |
| |
|
